Free tool
Stocks far below their 52-week high
We cover 19 companies trading at least 50% below their own 52-week high. The median market value in the group is $69.12B. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −86.1% to −41.9% across the middle 80 percent of the group, with a median of −54.4%.
Other lists in this group
Table
19 of 4,095 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GILD34.SA | Gilead Sciences, Inc. | $184.15B | Large cap | −79.11% |
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | $139.70B | Large cap | −83.18% |
| MDTC34.SA | Medtronic plc | $118.37B | Large cap | −75.74% |
| M1CK34.SA | McKesson Corporation | $104.59B | Large cap | −92.49% |
| ESL.DE | EssilorLuxottica Société anonyme | $85.76B | Large cap | −39.11% |
| EL.PA | EssilorLuxottica Société anonyme | $85.31B | Large cap | −38.15% |
| C1IC34.SA | The Cigna Group | $73.39B | Large cap | −85.33% |
| B1SX34.SA | Boston Scientific Corporation | $70.04B | Large cap | −89.24% |
| BSX | Boston Scientific Corporation | $69.81B | Large cap | −54.50% |
| BSX.DE | Boston Scientific Corporation | $69.12B | Large cap | −53.11% |
| A1GI34.SA | Agilent Technologies, Inc. | $39.64B | Large cap | −77.37% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −47.38% |
| ZOE.DE | Zoetis Inc. | $32.08B | Large cap | −49.47% |
| ZTS | Zoetis Inc. | $32.03B | Large cap | −49.50% |
| Z1TS34.SA | Zoetis Inc. | $32.03B | Large cap | −52.31% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | $31.78B | Large cap | −49.35% |
| SMMT | Summit Therapeutics Inc. | $11.35B | Large cap | −42.63% |
| AFW.DE | Align Technology, Inc. | $11.26B | Large cap | −54.37% |
| I1QV34.SA | IQVIA Holdings Inc. | $10.82B | Large cap | −67.19% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.